T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer

scientific article

T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...868171M
P356DOI10.1371/JOURNAL.PONE.0068171
P3181OpenCitations bibliographic resource ID1333011
P932PMC publication ID3730734
P698PubMed publication ID23935856
P5875ResearchGate publication ID255737018

P2093author name stringRicardo Bentes Azevedo
Adriana Bonomo
Triciana Gonçalves-Silva
Sacha Braun Chaves
Ana Carolina Monteiro
Ana Carolina Leal
João P Monteiro
Fabiola Kestelman
Ana Carolina T Mercadante
P2860cites workHallmarks of Cancer: The Next GenerationQ22252312
RANK is essential for osteoclast and lymph node developmentQ24598872
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancerQ24605866
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotionQ27860475
The blockade of immune checkpoints in cancer immunotherapyQ27860852
TRANCE is a TNF family member that regulates dendritic cell and osteoclast functionQ28137948
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland developmentQ28142247
Matrix-embedded cells control osteoclast formationQ28247746
A novel orthotopic model of breast cancer metastasis to bone.Q52826484
Spontaneous mammary adenocarcinoma in mice: influence of thymectomy and reconstitution with thymus grafts or spleen cells.Q53993813
Treg cells suppress osteoclast formation: a new link between the immune system and boneQ56900960
Effect of Early Thymectomy on Development of Mammary Tumours in MiceQ58964947
Accelerated development of spontaneous mammary tumors in mice pretreated with mammary tumor tissue and adjuvantQ78881976
Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal diseaseQ79929436
Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humansQ83155016
Evidence for osteocyte regulation of bone homeostasis through RANKL expressionQ28247757
Cancer despite immunosurveillance: immunoselection and immunosubversionQ28263865
Microenvironmental regulation of metastasisQ29547660
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisitedQ29547915
Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionQ29614274
Metastasis to bone: causes, consequences and therapeutic opportunitiesQ29614310
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapyQ29618033
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METQ29618139
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandQ29619331
New insights into the role of T cells in the vicious cycle of bone metastasesQ30440690
Mechanisms of bone metastasisQ33977526
Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancerQ34000467
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept studyQ34096856
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumorQ34352016
Malignant cells facilitate lung metastasis by bringing their own soilQ34411553
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowQ34755120
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophagesQ34995099
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signallingQ35194008
IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activationQ35219971
IMMUNOLOGY OF EXPERIMENTAL TUMORS.Q35434728
Expression of tumour-specific antigens underlies cancer immunoeditingQ35785378
In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche.Q37051371
ST2 deletion enhances innate and acquired immunity to murine mammary carcinomaQ37101727
Radiologic measurements of tumor response to treatment: practical approaches and limitations.Q37113203
Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgeneQ37265676
T-lymphocyte interaction with stromal, bone and hematopoietic cells in the bone marrow.Q37333685
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoeditingQ37418530
Osteoimmunology and the effects of the immune system on boneQ37626412
RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasisQ39365550
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myelomaQ39483693
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destructionQ41927546
Normal hematopoiesis is maintained by activated bone marrow CD4+ T cellsQ42469876
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectosteolysisQ2035084
metastatic breast cancerQ12859063
P304page(s)e68171
P577publication date2013-01-01
P1433published inPLOS OneQ564954
P1476titleT cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer
P478volume8